Although prior studies observed radiosensitization in response to treatment with dual PI3K/mTOR inhibitors (in other cancer cell lines both in vitro and in vivo) [20, 21], an in vitro condition does not truly represent clinical scenarios. The gene discussed is MTOR; the disease is cancer.